Trial Details
COMPLETEDBasic Information
| Clinical ID | c1414 |
|---|---|
| Identifier | NCT05078879 |
| Trial Title | Empagliflozin as a Treatment for Severe Congenital Neutropenia Due to G6PC3 Deficiency |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease|Glycogen Metabolism|Inflammatory Bowel Disease (IBD) |
| Interventions | DRUG: Empagliflozin |
Participant Information
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
|---|---|
| City | Bethesda |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2021-11-16 |
|---|---|
| Primary Completion Date | 2025-05-02 |
| Completion Date | 2025-05-21 |